In addition to adipokines, increased expression of genes such as Pcsk1 and Hmox1, which play important roles in preventing obesity and metabolic disease, could potentially contribute to reducing the risk of metabolic disease post slurry treatment30,31. Here, PCSK1 is linked to metabolic disease.